Eli Lilly (LLY) Goodwill (2009 - 2026)
Eli Lilly (LLY) posted Goodwill of $6.1 billion for Q1 2026, up 3.93% quarter-over-quarter from $5.9 billion in Q4 2025, and up 6.23% year-on-year from $5.8 billion in Q1 2025.
Eli Lilly (LLY) Goodwill (2009 - 2026) Analysis & Trends
Eli Lilly (LLY) has reported Goodwill for 18 consecutive years, with $6.1 billion the latest figure, recorded in Q1 2026.
- Goodwill for Q1 2026 came in at $6.1 billion, up 6.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.1 billion (up 6.23% YoY), and the FY2025 annual result was $5.9 billion, up 2.22% from the prior year.
- Goodwill was $6.1 billion for Q1 2026 at Eli Lilly, up from $5.9 billion in the prior quarter.
- Over five years, Goodwill peaked at $6.1 billion in Q1 2026 and troughed at $3.9 billion in Q3 2022.
- Average Goodwill over 5 years is $5.0 billion, with a median of $4.9 billion recorded in 2023.
- Year-over-year, Goodwill surged 41.42% in 2024 and rose 0.04% in 2025.
- Over 5 years, Goodwill stood at $4.1 billion in 2022, then grew by 21.28% to $4.9 billion in 2023, then increased by 16.81% to $5.8 billion in 2024, then grew by 2.22% to $5.9 billion in 2025, then rose by 3.93% to $6.1 billion in 2026.
- Per Business Quant data, the three most recent Goodwill figures were $6.1 billion in Q1 2026, $5.9 billion in Q4 2025, and $5.9 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.13 Bn |
| Dec 31, 2025 | 5.90 Bn |
| Sep 30, 2025 | 5.90 Bn |
| Jun 30, 2025 | 5.77 Bn |
| Mar 31, 2025 | 5.77 Bn |
| Dec 31, 2024 | 5.77 Bn |
| Sep 30, 2024 | 5.77 Bn |
| Jun 30, 2024 | 5.77 Bn |
| Mar 31, 2024 | 4.94 Bn |
| Dec 31, 2023 | 4.94 Bn |
| Sep 30, 2023 | 4.09 Bn |
| Jun 30, 2023 | 4.08 Bn |
| Mar 31, 2023 | 4.07 Bn |
| Dec 31, 2022 | 4.07 Bn |
| Sep 30, 2022 | 3.89 Bn |
| Jun 30, 2022 | 3.89 Bn |
| Mar 31, 2022 | 3.89 Bn |
| Dec 31, 2021 | 3.89 Bn |
| Sep 30, 2021 | 3.88 Bn |
| Jun 30, 2021 | 3.88 Bn |